DK2014671T3 - Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C - Google Patents

Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C

Info

Publication number
DK2014671T3
DK2014671T3 DK08014584.0T DK08014584T DK2014671T3 DK 2014671 T3 DK2014671 T3 DK 2014671T3 DK 08014584 T DK08014584 T DK 08014584T DK 2014671 T3 DK2014671 T3 DK 2014671T3
Authority
DK
Denmark
Prior art keywords
characterization
compositions
identification
methods
hcv
Prior art date
Application number
DK08014584.0T
Other languages
English (en)
Inventor
Carol Holland-Staley
Original Assignee
Lab 21 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab 21 Ltd filed Critical Lab 21 Ltd
Application granted granted Critical
Publication of DK2014671T3 publication Critical patent/DK2014671T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DK08014584.0T 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C DK2014671T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36360302P 2002-03-11 2002-03-11
EP03714097A EP1490383B1 (en) 2002-03-11 2003-03-11 Methods and compositions for identifying and characterizing hepatitis c

Publications (1)

Publication Number Publication Date
DK2014671T3 true DK2014671T3 (da) 2010-09-20

Family

ID=28041784

Family Applications (3)

Application Number Title Priority Date Filing Date
DK08014584.0T DK2014671T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C
DK03714097T DK1490383T3 (da) 2002-03-11 2003-03-11 Fremgangsmåde og sammensætning til identifikation og karakterisering af hepatitis C
DK08000552.3T DK1947104T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK03714097T DK1490383T3 (da) 2002-03-11 2003-03-11 Fremgangsmåde og sammensætning til identifikation og karakterisering af hepatitis C
DK08000552.3T DK1947104T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C

Country Status (9)

Country Link
US (3) US20070172926A1 (da)
EP (3) EP1490383B1 (da)
AT (3) ATE423785T1 (da)
AU (2) AU2003218111B8 (da)
DE (2) DE60332781D1 (da)
DK (3) DK2014671T3 (da)
ES (3) ES2346717T3 (da)
PT (3) PT2014671E (da)
WO (1) WO2003077729A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003218111B8 (en) 2002-03-11 2008-11-20 Lab 21 Limited Methods and compositions for identifying and characterizing hepatitis C
CA2604442A1 (en) * 2005-04-11 2006-10-19 Mingjun Huang Pharmaceutical compositions for and methods of inhibiting hcv replication
US20090042814A1 (en) * 2005-10-14 2009-02-12 Ivan Petyaev Treatment and Diagnosis of Obligate Intracellular Pathogens
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
US20080014572A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for molecular inhibition
US20090082344A1 (en) * 2006-07-13 2009-03-26 Searete Llc Methods and systems for treating disease
US20080015835A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for treating disease
EP2527474A1 (en) 2006-10-20 2012-11-28 Innogenetics N.V. Methodology for analysis of sequence variations within the HCV NS3/4A genomic region
US20090325145A1 (en) 2006-10-20 2009-12-31 Erwin Sablon Methodology for analysis of sequence variations within the hcv ns5b genomic region
JP2011501953A (ja) * 2007-10-30 2011-01-20 インターミューン インコーポレイテッド Ｈｃｖ遺伝子型タイピングおよび表現型タイピング
CA2703765A1 (en) * 2007-10-31 2009-05-07 Debiopharm Sa Near full-genome assay of hcv drug resistance
EP2576823A1 (en) 2010-06-04 2013-04-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence
WO2012177739A2 (en) * 2011-06-20 2012-12-27 Siemens Healthcare Diagnostics Inc. Reagents and methods for detecting hcv
AU2013205064B2 (en) * 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
CN1049686C (zh) 1987-11-18 2000-02-23 希龙股份有限公司 非ａ和非ｂ肝炎病毒的诊断及疫苗
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0435229A1 (en) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
RO117329B1 (ro) * 1991-06-24 2002-01-30 Chiron Corp Emeryville Polipeptide care contin o secventa a virusului hepatitei c
US20030125270A1 (en) * 2000-12-18 2003-07-03 Lawrence Blatt Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
BR9405334A (pt) * 1993-04-27 1999-05-25 Innogenetics Nv Novas sequências de genótipos de vírus da hepatite c e seu uso como agentes terapêuticos e diagnóstico
JP3751315B2 (ja) * 1993-05-05 2006-03-01 コモン サーヴィシス エージェンシー Ｃ型肝炎ウイルス４、５及び６型
US5571673A (en) * 1994-11-23 1996-11-05 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US7338759B1 (en) * 1997-03-04 2008-03-04 Washington University HCV variants
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
EP1012334A4 (en) * 1997-07-30 2004-12-29 Virologic Inc COMPOSITIONS AND METHODS FOR DETERMINING SENSITIVITY AND RESISTANCE TO ANTIVIRAL DRUGS, AND SCREENING FOR ANTIVIRAL DRUGS
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
EP2011889B1 (en) * 2000-04-18 2011-09-28 Virco BVBA Methods for measuring drug resistance against HCV
IL152671A0 (en) * 2000-05-23 2003-06-24 Univ Washington Hcv variants
WO2002008447A2 (en) * 2000-07-24 2002-01-31 Institute Of Molecular & Cell Biology Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
AU2003218111B8 (en) 2002-03-11 2008-11-20 Lab 21 Limited Methods and compositions for identifying and characterizing hepatitis C

Also Published As

Publication number Publication date
ES2386742T3 (es) 2012-08-28
EP1947104A2 (en) 2008-07-23
WO2003077729A2 (en) 2003-09-25
US20090047663A1 (en) 2009-02-19
AU2008249300A1 (en) 2008-12-18
DE60326327D1 (de) 2009-04-09
DK1490383T3 (da) 2009-06-08
AU2003218111B2 (en) 2008-11-06
US8173795B2 (en) 2012-05-08
EP1947104A3 (en) 2009-04-08
DE60332781D1 (de) 2010-07-08
EP1490383A4 (en) 2005-12-21
AU2008249300B2 (en) 2012-08-16
ATE469162T1 (de) 2010-06-15
EP1490383A2 (en) 2004-12-29
ATE423785T1 (de) 2009-03-15
US20070172926A1 (en) 2007-07-26
EP2014671B1 (en) 2010-05-26
ES2346717T3 (es) 2010-10-19
US20120322051A1 (en) 2012-12-20
ATE556084T1 (de) 2012-05-15
WO2003077729A9 (en) 2004-04-22
AU2003218111A1 (en) 2003-09-29
DK1947104T3 (da) 2012-08-06
AU2003218111B8 (en) 2008-11-20
PT1490383E (pt) 2009-05-25
PT2014671E (pt) 2010-06-16
EP1490383B1 (en) 2009-02-25
ES2321498T3 (es) 2009-06-08
PT1947104E (pt) 2012-08-09
WO2003077729A3 (en) 2004-06-03
EP1947104B1 (en) 2012-05-02
EP2014671A1 (en) 2009-01-14

Similar Documents

Publication Publication Date Title
DK2014671T3 (da) Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C
DE60233462D1 (de) Neue Zusammensetzung und Methode zur 'hot start' Nukleinsäureamplifizierung
ATE432365T1 (de) Verfahren, kits und reagenzien zur nukleinsäuresequenzierung
DK1026262T3 (da) Oligonukleotidprimere til effektiv detektering af hepatitis C-virus (HCV) og fremgangsmåder til anvendelse deraf
DK1218542T3 (da) Fremgangsmåder og sammensætninger til lineær isotermisk amplifikation af polynukleotidsekvenser
DK1423400T4 (da) Evolution af hidtil ukendt molekylfunktion
HK1074458A1 (en) Thermostable taq polymerase fragment
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
DE60143314D1 (de) Estimmung der präsenz von cryptosporidium organismen in einer testprobe
ATE427362T1 (de) Polymorphe marker des lsr-gens
ATE516365T1 (de) Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer
DE602005023586D1 (de) Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv
ATE312204T1 (de) Methoden und zusammensetzungen zur detektion von spezies des mycobacterium avium-komplexes
NO20000537D0 (no) Oligonukleotidprimere for effektiv reverstranskripsjon av Hepatitis C-virus (HCV) RNA og metoder for anvendelse derav
ATE414175T1 (de) Detektion von rpob sequenzen von mycobacterium tuberculosis
ATE486932T1 (de) Thermostabile dna polymerase von archae ampullavirus abv und dessen verwendungen
ATE440153T1 (de) Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie